巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    STERIS plc

    STE
    234.580
    ▲3.850
    ▲1.67%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・STERIS plc - 延遲價格・最後更新於 27/05 2:55
    最高位
    235.290
    最低位
    231.555
    開市價
    --
    前收市價
    230.730
    成交量(千)
    2.36
    成交額(百萬)
    4.71
    買入
    234.510
    賣出
    234.700
    每手股數
    --
    市值(百萬)
    23,487.84
    市盈率
    78.450
    息率
    0.72%
    差價
    --
    52週高低
    255.933 - 188.100
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    STERIS plc
    證券代碼
    STE.US
    所屬板塊
    Medical Devices
    公司業務
    Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
    發行量
    99676813
    公司總部
    5960 Heisley Road
    公司網址
    https://www.steris-ir.com
    公司電郵
    Julie_Winter@steris.com
    公司電話
    +1 440 354-2600

    最新發佈

    暫無內容

    關於

    STERIS plc(STE.US)所屬的行業板塊為Medical Devices。
    Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
    截至27/05 02:55:19，STERIS plc的股價升1.67，市值23,487.84百萬。STERIS plc的市盈率及息率分別為78.450及0.72%。
    詳細公司背景可參考: https://www.steris-ir.com。